Olivier Kitten

Affilogic

BIOGRAPHY

Olivier Kitten is the Founder and CEO of Affilogic, a biotech company specializing in the development of alternative non-antibody ligands. His work focuses on the Nanofitin© platform, an engineered protein scaffold technology with applications in targeted drug therapy and clinical diagnostics.

Olivier draws on experience in the pharmaceutical industry and gene therapy to lead Affilogic's business strategy and external partnerships. His programs advance proprietary Nanofitins© toward clinical applications, with strategic alliances supporting the translational development of therapeutic and diagnostic ligand-based approaches.